Hepatic metastatic niche: from normal to pre-metastatic and metastatic niche

Tumor Biology

Volumn 37, Issue 2, 2016, Pages 1493-1503

  Azizidoost, Shirin ^a   Ahmadzadeh, Ahmad ^a   Rahim, Fakher ^a   Shahjahani, Mohammad ^a   Seghatoleslami, Mohammad ^a   Saki, Najmaldin ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chemokine; Hepatic metastatic niche; Hepatic stem cell; MiRNA

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; CELL PROTEIN; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; DELTA LIKE HOMOLOG 1; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 1; INTERLEUKIN 6; JAGGED1; MICRORNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STAT3 PROTEIN; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; TENASCIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1; WNT PROTEIN;

BIOINFORMATICS; CANCER INFILTRATION; COLON CANCER; CYTOKINE RELEASE; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENETIC VARIABILITY; HEPATIC METASTATIC NICHE; HEPATIC STEM CELL NICHE; LIVER CANCER; LIVER CELL; LIVER DEVELOPMENT; LIVER FUNCTION; LIVER METASTASIS; LUNG CANCER; MALIGNANT TRANSFORMATION; ONCOLOGICAL PARAMETERS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STEM CELL NICHE; CANCER STEM CELL; CELL TRANSFORMATION; HUMAN; LIVER TUMOR; METASTASIS; PATHOLOGY; SECONDARY;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; STEM CELL NICHE;

EID: 84949667798     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4557-x     Document Type: Review

References (79)

1. Zhang Y, Davis C, Ryan J, Janney C, Peña MMO. Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver. Clin Exp Metastasis. 2013;30(7):903–18.
2. Greenbaum LE, Wells RG. The role of stem cells in liver repair and fibrosis. Int J Biochem Cell Biol. 2011;43(2):222–9.
3. Xia M, Hu M. The role of microRNA in tumor invasion and metastasis. J Cancer Mol. 2010;5(2):33–9.
4. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA. MicroRNAs—the micro steering wheel of tumour metastases. Nat Rev Cancer. 2009;9(4):293–302.
5. Katoonizadeh A, Poustchi H. Adult hepatic progenitor cell niche: how it affects the progenitor cell fate. Middle East J Digestive Dis. 2014;6(2):57–64.
6. Clark AM, Wheeler SE, Taylor DP, Pillai VC, Young CL, Prantil-Baun R, et al. A microphysiological system model of therapy for liver micrometastases. Exp Biol Med. 2014;239(9):1170–9.
7. Payushina OV. Hematopoietic microenvironment in the fetal liver: roles of different cell populations. ISRN Cell Biology. 2012;2012:1–7.
8. Oertel M, Shafritz DA. Stem cells, cell transplantation and liver repopulation. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2008;1782(2):61–74.
9. Kuwahara R, Kofman AV, Landis CS, Swenson ES, Barendswaard E, Theise ND. The hepatic stem cell niche: identification by label-retaining cell assay. Hepatology. 2008;47(6):1994–2002.
10. Petersen B, Shupe T. Location is everything: the liver stem cell niche. Hepatology. 2008;47(6):1810–2.
11. Kamiya A, Kakinuma S, Yamazaki Y, Nakauchi H. Enrichment and clonal culture of progenitor cells during mouse postnatal liver development in mice. Gastroenterology. 2009;137(3):1114–26.
12. Vestentoft PS. Development and molecular composition of the hepatic progenitor cell niche. Danish Med J. 2013;60(5):B4640-B.
13. Villeneuve J, Pelluard-Nehme F, Combe C, Carles D, Chaponnier C, Ripoche J, et al. Immunohistochemical study of the phenotypic change of the mesenchymal cells during portal tract maturation in normal and fibrous (ductal plate malformation) fetal liver. Comp Hepatol. 2009;8(5):1–12.
14. Kiassov AP, Van Eyken P, van Pelt JF, Depla E, Fevery J, Desmet VJ, et al. Desmin expressing nonhematopoietic liver cells during rat liver development: an immunohistochemical and morphometric study. Differentiation. 1995;59(4):253–8.
15. Fujio K, Evarts RP, Hu Z, Marsden ER, Thorgeirsson SS. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. Laboratory Investig J Tech Methods Pathol. 1994;70(4):511–6.
16. Kordes C, Sawitza I, Götze S, Häussinger D. Hepatic stellate cells support hematopoiesis and are liver-resident mesenchymal stem cells. Cell Physiol Biochem. 2013;31(2–3):290–304.
17. Li D, Wang G-Y, Liu Z-F, Shi Y-X, Zhang H, Bai Z-L. Macrophage-associated erythropoiesis and lymphocytopoiesis in mouse fetal liver: ultrastructural and ISH analysis. Cell Biol Int. 2004;28(6):457–61.
18. Van den Eynden GG, Majeed AW, Illemann M, Vermeulen PB, Bird NC, Høyer-Hansen G, et al. The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications. Cancer Res. 2013;73(7):2031–43.
19. Isern J, Fraser ST, He Z, Baron MH. The fetal liver is a niche for maturation of primitive erythroid cells. Proc Natl Acad Sci. 2008;105(18):6662–7.
20. Lee WB, Erm SK, Kim KY, Becker RP. Emperipolesis of erythroblasts within kupffer cells during hepatic hemopoiesis in human fetus. Anat Rec. 1999;256(2):158–64.
21. Kodama Y, Hijikata M, Kageyama R, Shimotohno K, Chiba T. The role of notch signaling in the development of intrahepatic bile ducts. Gastroenterology. 2004;127(6):1775–86.
22. Morell CM, Strazzabosco M. Notch signaling and new therapeutic options in liver disease. J Hepatol. 2014;60(4):885–90.
23. Zong Y, Panikkar A, Xu J, Antoniou A, Raynaud P, Lemaigre F, et al. Notch signaling controls liver development by regulating biliary differentiation. Development. 2009;136(10):1727–39.
24. Vidal-Vanaclocha F. The Tumor microenvironment at different stages of hepatic metastasis. In: Brodt P, editor. 1st ed. Liver metastasis: biology and clinical management; 2011.
25. Seubert B, Grünwald B, Kobuch J, Cui H, Schelter F, Schaten S, et al. Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatology. 2015;61(1):238–48.
26. Kopitz C, Gerg M, Bandapalli OR, Ister D, Pennington CJ, Hauser S, et al. Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res. 2007;67(18):8615–23.
27. Tanaka M, Itoh T, Tanimizu N, Miyajima A. Liver stem/progenitor cells: their characteristics and regulatory mechanisms. J Biochem. 2011;149(3):231–9.
28. Chirco R, Liu X-W, Jung K-K, Kim H-RC. Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev. 2006;25(1):99–113.
29. Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer. 2009;9(4):285–93.
30. Dachs G, Tozer G. Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation. Eur J Cancer. 2000;36(13):1649–60.
31. Benvenuti S, Comoglio PM. The MET receptor tyrosine kinase in invasion and metastasis. J Cell Physiol. 2007;213(2):316–25.
32. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell. 2003;3(4):347–61.
33. Schelter F, Halbgewachs B, Bäumler P, Neu C, Görlach A, Schrötzlmair F, et al. Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α. Clin Exp Metastasis. 2011;28(2):91–9.
34. Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, Wang XH, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res. 2006;12(18):5369–76.
35. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438(7069):820–7.
36. Ma S, Chan KW, Hu L, Lee TKW, Wo JYH, Ng IOL, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology. 2007;132(7):2542–56.
37. Gassmann P, Hemping-Bovenkerk A, Mees ST, Haier J. Metastatic tumor cell arrest in the liver–lumen occlusion and specific adhesion are not exclusive. Int J Color Dis. 2009;24(7):851–8.
38. Singh S, Sadanandam A, Singh RK. Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis Rev. 2007;26(3–4):453–67.
39. Khatib A-M, Auguste P, Fallavollita L, Wang N, Samani A, Kontogiannea M, et al. Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol. 2005;167(3):749–59.
40. Auguste P, Fallavollita L, Wang N, Burnier J, Bikfalvi A, Brodt P. The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. Am J Pathol. 2007;170(5):1781–92.
41. Khatib A-M, Kontogiannea M, Fallavollita L, Jamison B, Meterissian S, Brodt P. Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res. 1999;59(6):1356–61.
42. Yamamoto M, Kikuchi H, Ohta M, Kawabata T, Hiramatsu Y, Kondo K, et al. TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. Cancer Res. 2008;68(23):9754–62.
43. Spicer JD, McDonald B, Cools-Lartigue JJ, Chow SC, Giannias B, Kubes P, et al. Neutrophils promote liver metastasis via mac-1-mediated interactions with circulating tumor cells. Cancer Res. 2012;72(16):3919–27.
44. Fox-Robichaud A, Kubes P. Molecular mechanisms of tumor necrosis factor α-stimulated leukocyte recruitment into the murine hepatic circulation. Hepatology. 2000;31(5):1123–7.
45. Noël A, Jost M, Maquoi E. Matrix metalloproteinases at cancer tumor–host interface. Semin Cell Dev Biol. 2008;19(1):52–60.
46. Shi Y, Xu T, Li LP, Chen XP. Over-expression of VEGF and MMP-9 in residual tumor cells of hepatocellular carcinoma after embolization with lipidol. J Huazhong Univ Sci Technolog Med Sci. 2013;33:90–5.
47. Yamashita T, Wang XW. Cancer stem cells in the development of liver cancer. J Clin Invest. 2013;123(5):1911–8.
48. Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, et al. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis dissection of ras signaling pathways. J Cell Biol. 2002;156(2):299–314.
49. Burnier J, Wang N, Michel R, Hassanain M, Li S, Lu Y, et al. Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene. 2011;30(35):3766–83.
50. Wood SL, Pernemalm M, Crosbie PA, Whetton AD. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets. Cancer Treat Rev. 2014;40(4):558–66.
51. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005;436(7050):518–24.
52. Irmisch A, Huelsken J. Metastasis: new insights into organ-specific extravasation and metastatic niches. Exp Cell Res. 2013;319(11):1604–10.
53. Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med. 2011;17(7):867–74.
54. Ye C, Kiriyama K, Mistuoka C, Kannagi R, Ito K, Watanabe T, et al. Expression of E-selectin on endothelial cells of small veins in human colorectal cancer. Int J Cancer. 1995;61(4):455–60.
55. Sato T, Oshima T, Yoshihara K, Yamamoto N, Yamada R, Nagano Y, et al. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer. Oncol Rep. 2009;21(1):211–6.
56. Li M, Lin Y-M, Hasegawa S, Shimokawa T, Murata K, Kameyama M, et al. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol. 2004;24(2):305–12.
57. Osada T, Sakamoto M, Ino Y, Iwamatsu A, Matsuno Y, Muto T, et al. E‐cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 1996;24(6):1460–7.
58. Kinugasa T, Akagi Y, Ochi T, Tanaka N, Kawahara A, Ishibashi Y, et al. Increased claudin-1 protein expression in hepatic metastatic lesions of colorectal cancer. Anticancer Res. 2012;32(6):2309–14.
59. Niedergethmann M, Alves F, Neff J, Heidrich B, Aramin N, Li L, et al. Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model. Br J Cancer. 2007;97(10):1432–40.
60. Shi Q, Le X, Abbruzzese JL, Peng Z, Qian C-N, Tang H, et al. Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. Cancer Res. 2001;61(10):4143–54.
61. Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene. 2003;22(3):319–29.
62. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem. 1995;270(22):13333–40.
63. Zlotnik A. Chemokines in neoplastic progression. Semin Cancer Biol. 2004;14(3):181–5.
64. Saur D, Seidler B, Schneider G, Algül H, Beck R, Senekowitsch–Schmidtke R, et al. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology. 2005;129(4):1237–50.
65. Cho WC. OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer. 2007;6(60):1–7.
66. Davoodian N, Lotfi AS, Soleimani M, Mola SJ, Arjmand S. Let-7f microRNA negatively regulates hepatic differentiation of human adipose tissue-derived stem cells. J Physiol Biochem. 2014;70(3):781–9.
67. Qi W, Liang W, Jiang H, Waye MM. The function of miRNA in hepatic cancer stem cell. BioMed Res Int. 2013;2013:1–9.
68. Chen H, Miao R, Fan J, Han Z, Wu J, Qiu G, et al. Decreased expression of miR-126 correlates with metastatic recurrence of hepatocellular carcinoma. Clin Exp Metastasis. 2013;30(5):651–8.
69. Crawford M, Brawner E, Batte K, Yu L, Hunter M, Otterson G, et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun. 2008;373(4):607–12.
70. Wang H, Zhu Y, Zhao M, Wu C, Zhang P, Tang L, et al. miRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin beta1 and matrix metalloproteinase2 (MMP2). PloS one. PLoS One. 2013 6;8(8):e70192
71. Ji D, Chen Z, Li M, Zhan T, Yao Y, Zhang Z, et al. MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1. Mol Cancer. 2014;13(1):86.
72. Tsai WC, Hsu PWC, Lai TC, Chau GY, Lin CW, Chen CM, et al. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 2009;49(5):1571–82.
73. Zhang X, Liu S, Hu T, Liu S, He Y, Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology. 2009;50(2):490–9.
74. Yao J, Liang L, Huang S, Ding J, Tan N, Zhao Y, et al. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology. 2010;51(3):846–56.
75. Liang L, Wong CM, Ying Q, Fan DNY, Huang S, Ding J, et al. MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology. 2010;52(5):1731–40.
76. Kahlert C, Klupp F, Brand K, Lasitschka F, Diederichs S, Kirchberg J, et al. Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases. Cancer Sci. 2011;102(10):1799–807.
77. Zhang Y, He X, Liu Y, Ye Y, Zhang H, He P, et al. MicroRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer. Oncol Rep. 2012;27(3):685–94.
78. Kyutoku M, Taniyama Y, Katsuragi N, Shimizu H, Kunugiza Y, Iekushi K, et al. Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model. Int J Mol Med. 2011;28(2):181–6.
79. Wang J, Fallavollita L, Brodt P. Inhibition of experimental hepatic metastasis by a monoclonal antibody that blocks tumor-hepatocyte interaction. J Immunother. 1994;16(4):294–302.